Revenue
2022
2023
2024
2025
Baird Medical Investment Holdings Ltd (BDMD)
Price$1.09Cached quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $22.5M | $37.0M | $31.5M | $35.1M | — |
| Gross profit | $18.9M | $32.7M | $27.2M | $28.0M | — |
| Gross margin | 83.79% | 88.16% | 86.56% | 79.90% | — |
| Research & development | $20.1M | $6.2M | $4.3M | $3.9M | — |
| Operating expenses | $44.5M | $17.3M | $15.4M | $14.4M | — |
| Operating income | −$25.6M | $15.3M | $11.9M | $13.6M | — |
| Operating margin | −113.73% | 41.35% | 37.71% | 38.85% | — |
| EBITDA | −$24.5M | $16.5M | $12.9M | $14.5M | — |
| EBITDA margin | −108.83% | 44.43% | 40.93% | 41.46% | — |
| Net income | −$27.3M | $12.5M | $10.5M | $12.8M | — |
| Net profit margin | −121.04% | 33.62% | 33.52% | 36.41% | — |
| Basic EPSper basic share | -$0.98 | $0.57 | $0.51 | $0.49 | $0.39 |
| Diluted EPSper diluted share | -$0.98 | $0.57 | $0.51 | $0.49 | $0.39 |
Owners
Reported shareholders